New Key Statistics Module, Z-Score and F-Score
NAS:FENC Key Ratios
Market Cap $ M | 121.71 |
Enterprise Value $ M | 112.35 |
P/E(ttm) | 111.75 |
PE Ratio without NRI | 103.95 |
Forward PE Ratio | 26.77 |
Price/Book | -- |
Price/Sales | 2.72 |
Price/Free Cash Flow | 6.90 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 48.00 |
EPS (TTM) $ | 0.04 |
Beneish M-Score | 2.66 |
10-y EBITDA Growth Rate % | -17.10 |
5-y EBITDA Growth Rate % | 0.20 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 17.06 |
EV-to-EBITDA | 15.03 |
PEG | 519.75 |
Shares Outstanding M | 27.36 |
Net Margin (%) | 5.50 |
Operating Margin % | 11.58 |
Pre-tax Margin (%) | 5.50 |
Quick Ratio | 7.75 |
Current Ratio | 8.02 |
ROA % (ttm) | 6.80 |
ROE % (ttm) | 10,000.00 |
ROIC % (ttm) | 92.32 |
Dividend Yield % | -- |
Altman Z-Score | -1.40 |
FENC Number of Guru Trades
FENC Volume of Guru Trades
Gurus Latest Trades with NAS:FENC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:FENC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Fennec Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:FENC
Total 0- 1